Boehringer Ingelheim and N-SIDE partner on innovative production planning optimization project

Boehringer Ingelheim Pharma has signed an agreement with N-SIDE to start a pilot project using N-SIDE’s risk-based production planning solution, CT-PRO. Boehringer Ingelheim joins other top pharmaceutical companies, such as Sanofi, who have recently partnered with N-SIDE for projects focused on production optimization.   The project will evaluate optimization opportunities for the supply chain of two early phase clinical compounds […]

read more

Accelerate time to market with clinical supply optimization

End-to-end clinical supply optimization brings many benefits including increased transparency and efficiency as well as risk management, ensuring 100% patient service levels. But it also results in freeing up manufacturing time and being able to start new trials sooner. Learn more about how end-to-end clinical supply optimization can accelerate time to market:     Also […]

read more

Today at the Clinical Trial Supply Forum 2019 !

Join us at the Clinical Trial Supply Forum, in Brussels. On May 20th, Sébastien Coppe, Head of Consulting Group at N-SIDE, will be co-presenting with Didier Basseras, Vice President Clinical Supplies at Sanofi-Aventis : “Evolving from Push to Pull Clinical Supply Chain Management with Early Phase Optimization” The participants will learn how to : Optimize […]

read more
v